Literature DB >> 11036013

Purification and biochemical characterization of the VIM-1 metallo-beta-lactamase.

N Franceschini1, B Caravelli, J D Docquier, M Galleni, J M Frère, G Amicosante, G M Rossolini.   

Abstract

VIM-1 is a new group 3 metallo-beta-lactamase recently detected in carbapenem-resistant nosocomial isolates of Pseudomonas aeruginosa from the Mediterranean area. In this work, VIM-1 was purified from an Escherichia coli strain carrying the cloned bla(VIM-1) gene by means of an anion-exchange chromatography step followed by a gel permeation chromatography step. The purified enzyme exhibited a molecular mass of 26 kDa in sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and an acidic pI of 5.1 in analytical isoelectric focusing. Amino-terminal sequencing showed that mature VIM-1 results from the removal of a 26-amino-acid signal peptide from the precursor. VIM-1 hydrolyzes a broad array of beta-lactam compounds, including penicillins, narrow- to expanded-spectrum cephalosporins, carbapenems, and mechanism-based serine-beta-lactamase inactivators. Only monobactams escape hydrolysis. The highest catalytic constant/K(m) ratios (>10(6) M(-1). s(-1)) were observed with carbenicillin, azlocillin, some cephalosporins (cephaloridine, cephalothin, cefuroxime, cefepime, and cefpirome), imipenem, and biapenem. Kinetic parameters showed remarkable variability with different beta-lactams and also within the various penam, cephem, and carbapenem compounds, resulting in no clear preference of the enzyme for any of these beta-lactam subfamilies. Significant differences were observed with some substrates between the kinetic parameters of VIM-1 and those of other metallo-beta-lactamases. Inactivation assays carried out with various chelating agents (EDTA, 1,10-o-phenanthroline, and pyridine-2,6-dicarboxylic acid) indicated that formation of a ternary enzyme-metal-chelator complex precedes metal removal from the zinc center of the protein and revealed notable differences in the inactivation parameters of VIM-1 with different agents.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11036013      PMCID: PMC101593          DOI: 10.1128/AAC.44.11.3003-3007.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  27 in total

1.  Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece.

Authors:  A Tsakris; S Pournaras; N Woodford; M F Palepou; G S Babini; J Douboyas; D M Livermore
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

2.  Enzyme kinetics and biochemical analysis of ImiS, the metallo-beta-lactamase from Aeromonas sobria 163a.

Authors:  T R Walsh; S Gamblin; D C Emery; A P MacGowan; P M Bennett
Journal:  J Antimicrob Chemother       Date:  1996-03       Impact factor: 5.790

Review 3.  A functional classification scheme for beta-lactamases and its correlation with molecular structure.

Authors:  K Bush; G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

4.  Biochemical characterization of the carbapenem-hydrolyzing beta-lactamase AsbM1 from Aeromonas sobria AER 14M: a member of a novel subgroup of metallo-beta-lactamases.

Authors:  Y Yang; K Bush
Journal:  FEMS Microbiol Lett       Date:  1996-04-01       Impact factor: 2.742

5.  PCR detection of metallo-beta-lactamase gene (blaIMP) in gram-negative rods resistant to broad-spectrum beta-lactams.

Authors:  K Senda; Y Arakawa; S Ichiyama; K Nakashima; H Ito; S Ohsuka; K Shimokata; N Kato; M Ohta
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

6.  Kinetic analysis of extension of substrate specificity with Xanthomonas maltophilia, Aeromonas hydrophila, and Bacillus cereus metallo-beta-lactamases.

Authors:  A Felici; G Amicosante
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

7.  Multifocal outbreaks of metallo-beta-lactamase-producing Pseudomonas aeruginosa resistant to broad-spectrum beta-lactams, including carbapenems.

Authors:  K Senda; Y Arakawa; K Nakashima; H Ito; S Ichiyama; K Shimokata; N Kato; M Ohta
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

8.  An overview of the kinetic parameters of class B beta-lactamases.

Authors:  A Felici; G Amicosante; A Oratore; R Strom; P Ledent; B Joris; L Fanuel; J M Frère
Journal:  Biochem J       Date:  1993-04-01       Impact factor: 3.857

9.  Molecular characterization of an enterobacterial metallo beta-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance.

Authors:  E Osano; Y Arakawa; R Wacharotayankun; M Ohta; T Horii; H Ito; F Yoshimura; N Kato
Journal:  Antimicrob Agents Chemother       Date:  1994-01       Impact factor: 5.191

10.  A novel integron-like element carrying the metallo-beta-lactamase gene blaIMP.

Authors:  Y Arakawa; M Murakami; K Suzuki; H Ito; R Wacharotayankun; S Ohsuka; N Kato; M Ohta
Journal:  Antimicrob Agents Chemother       Date:  1995-07       Impact factor: 5.191

View more
  43 in total

1.  CENTA as a chromogenic substrate for studying beta-lactamases.

Authors:  C Bebrone; C Moali; F Mahy; S Rival; J D Docquier; G M Rossolini; J Fastrez; R F Pratt; J M Frère; M Galleni
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  Novel variant (bla(VIM-4)) of the metallo-beta-lactamase gene bla(VIM-1) in a clinical strain of Pseudomonas aeruginosa.

Authors:  Spyros Pournaras; Athanassios Tsakris; Maria Maniati; Leonidas S Tzouvelekis; Antonios N Maniatis
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

3.  VIM-4 in a carbapenem-resistant strain of Pseudomonas aeruginosa isolated in Sweden.

Authors:  Christian G Giske; Margareta Rylander; Göran Kronvall
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

4.  Biochemical Characterization of VIM-39, a VIM-1-Like Metallo-β-Lactamase Variant from a Multidrug-Resistant Klebsiella pneumoniae Isolate from Greece.

Authors:  Costas C Papagiannitsis; Simona Pollini; Filomena De Luca; Gian Maria Rossolini; Jean-Denis Docquier; Jaroslav Hrabák
Journal:  Antimicrob Agents Chemother       Date:  2015-09-14       Impact factor: 5.191

5.  Coproduction of KPC-18 and VIM-1 Carbapenemases by Enterobacter cloacae: Implications for Newer β-Lactam-β-Lactamase Inhibitor Combinations.

Authors:  Gina K Thomson; James W Snyder; Christi L McElheny; Kenneth S Thomson; Yohei Doi
Journal:  J Clin Microbiol       Date:  2015-12-30       Impact factor: 5.948

6.  Biochemical Characterization of CPS-1, a Subclass B3 Metallo-β-Lactamase from a Chryseobacterium piscium Soil Isolate.

Authors:  Dereje Dadi Gudeta; Simona Pollini; Jean-Denis Docquier; Valeria Bortolaia; Gian Maria Rossolini; Luca Guardabassi
Journal:  Antimicrob Agents Chemother       Date:  2015-12-14       Impact factor: 5.191

7.  Molecular characterization of a beta-lactamase gene, blaGIM-1, encoding a new subclass of metallo-beta-lactamase.

Authors:  Mariana Castanheira; Mark A Toleman; Ronald N Jones; Franz J Schmidt; Timothy R Walsh
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

8.  Biochemical characterization of the THIN-B metallo-beta-lactamase of Janthinobacterium lividum.

Authors:  Jean-Denis Docquier; Teresa Lopizzo; Sabrina Liberatori; Manuela Prenna; Maria Cristina Thaller; Jean-Marie Frère; Gian Maria Rossolini
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

9.  Discrepancies and interpretation problems in susceptibility testing of VIM-1-producing Klebsiella pneumoniae isolates.

Authors:  P Giakkoupi; L S Tzouvelekis; G L Daikos; V Miriagou; G Petrikkos; N J Legakis; A C Vatopoulos
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

Review 10.  Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions.

Authors:  L S Tzouvelekis; A Markogiannakis; M Psichogiou; P T Tassios; G L Daikos
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.